Neon Therapeutics

Neon Therapeutics

Neon Therapeutics

Neon Therapeutics is an immunooncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer.
Type
B2c
Founded
2015
Raised
$161M
Follow us
Alexa global traffic share
Xconomy

Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal

PE HUB

VC-backed Neon Therapeutics goes public

Stock markets Costs Health
Xconomy

Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines

Health Science
$70,000,000 Venture capital (Series B)
businesswire

Neon Therapeutics Secures $70 Million in Series B Financing | Business Wire

$55,000,000 Venture capital (Series A)
FinSMEs

Neon Therapeutics Raises $55M Series A Financing